Hernberg M - Search Results

1

Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.

Koskivuo I, Hernberg M, Vihinen P, Virolainen S, Talve L, Seppänen M, Vahlberg T, Jahkola T. Koskivuo I, et al. Among authors: hernberg m. Br J Surg. 2011 Oct;98(10):1400-7. doi: 10.1002/bjs.7565. Epub 2011 Jun 2. Br J Surg. 2011. PMID: 21638276

2

MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma.

Vlaykova T, Talve L, Hahka-Kemppinen M, Hernberg M, Muhonen T, Franssila K, Collan Y, Pyrhönen S. Vlaykova T, et al. Among authors: hernberg m. Oncology. 1999 Oct;57(3):242-52. doi: 10.1159/000012038. Oncology. 1999. PMID: 10545794

3

Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response.

Vlaykova T, Talve L, Hahka-Kemppinen M, Hernberg M, Muhonen T, Collan Y, Pyrhönen S. Vlaykova T, et al. Among authors: hernberg m. Oncology. 2002;62(3):259-68. doi: 10.1159/000059574. Oncology. 2002. PMID: 12065874

4

[Sentinel lymph node biopsy in patients with cutaneous melanoma].

Jahkola T, Virolainen S, Leppänen E, Suominen S, Hernberg M, Hahka-Kemppinen M, Saksela O. Jahkola T, et al. Among authors: hernberg m. Duodecim. 2002;118(22):2289-94. Duodecim. 2002. PMID: 12523105 Review. Finnish. No abstract available.

5

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma.

Vihinen PP, Hernberg M, Vuoristo MS, Tyynelä K, Laukka M, Lundin J, Ivaska J, Pyrhönen S. Vihinen PP, et al. Among authors: hernberg m. Melanoma Res. 2010 Aug;20(4):318-25. doi: 10.1097/CMR.0b013e3283390365. Melanoma Res. 2010. PMID: 20375744 Clinical Trial.

6

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.

Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Mirtti T, Alanen K, Kallajoki M, Vuoristo MS, Pyrhönen S, Heino J. Rappu P, et al. Among authors: hernberg m. Int J Cancer. 2011 May 15;128(10):2382-92. doi: 10.1002/ijc.25571. Int J Cancer. 2011. PMID: 20658534

7

[Are immunological treatments beneficial for malignant melanoma of the skin?].

Vihinen P, Vuoristo MS, Hernberg M, Pyrhönen S. Vihinen P, et al. Among authors: hernberg m. Duodecim. 2010;126(14):1701-10. Duodecim. 2010. PMID: 20804089 Review. Finnish.

8

Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.

Vihinen PP, Ramadan S, Vuoristo MS, Hernberg M, Tyynelä-Korhonen K, Skyttä T, Koskivuo I, Kellokumpu-Lehtinen PL, Syrjänen K, Pyrhönen S. Vihinen PP, et al. Among authors: hernberg m. Melanoma Res. 2011 Oct;21(5):431-7. doi: 10.1097/CMR.0b013e32834941d3. Melanoma Res. 2011. PMID: 21730877

9

Outcome following local recurrence or in-transit metastases in cutaneous melanoma.

Suojärvi NJ, Jahkola TA, Virolainen S, Ilmonen SK, Hernberg MM. Suojärvi NJ, et al. Among authors: hernberg mm. Melanoma Res. 2012 Dec;22(6):447-53. doi: 10.1097/CMR.0b013e32835a310c. Melanoma Res. 2012. PMID: 23059832

10

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, Stierner U, Pyrhönen S, Syrjänen K, Lundin J, Hernberg M. Vihinen P, et al. Among authors: hernberg m. Cancer Immunol Immunother. 2015 Feb;64(2):173-80. doi: 10.1007/s00262-014-1620-1. Epub 2014 Oct 16. Cancer Immunol Immunother. 2015. PMID: 25319807 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters